查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466484

切片检查引导系统市场：按产品、应用和最终用途 - 全球预测 2024-2030

Biopsy Guidance System Market by Product (MRI Guided Biopsy, Stereotactic Guided Biopsy, Ultrasound Guided Biopsy), Application (Brain Biopsy, Breast Biopsy, Lungs), End-Use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

切片检查引导系统市场规模预计2023年为14.4亿美元，预计2024年将达到15.4亿美元，2030年将达到23.8亿美元，复合年增长率为7.34%。

切片检查引导系统市场包括医疗设备和软体的销售和开拓，帮助医生确定进行切片检查的区域。这些切片检查引导系统利用超音波、磁振造影(MRI)、电脑断层扫描 (CT) 和其他影像引导技术等多种方式来准确定位异常组织，以便即时进行切片检查定位和目标。癌症和胃肠道疾病的增加增加了对切片检查引导系统的需求。人们对乳癌治疗和诊断的认识不断提高，以及对切片检查治疗的偏好，对市场成长做出了重大贡献。然而，製造切片检查引导系统的高成本可能会限制切片检查采用。此外，与切片检查引导系统相关的技术复杂性也是市场成长的问题。此外，切片检查引导系统的技术进步预计将为市场带来巨大的成长潜力。此外，医疗保健基础设施和医疗保健支出的改善预计也将为市场成长创造有吸引力的机会。

主要市场统计
基准年[2023] 14.4亿美元
预测年份 [2024] 15.4亿美元
预测年份 [2030] 23.8亿美元
复合年增长率（%） 7.34%

产品影像处理能力的增强推动了超音波引导切片检查的趋势

MRI 导引切片检查是一种微创手术，使用磁振造影(MRI) 来找出体内病变的确切位置并切除组织。 MRI 导引切片检查适用于在超音波或 X 光影像上无法看到病灶时进入异常区域。立体定位切片检查专门使用乳房X光摄影影像来定位和获取乳房组织的可疑区域。立体定位切片检查准确度高且成本效益高，适合门诊切片检查。超音波引导切片检查是一种广泛使用的手术，其中透过超音波辅助放置针进行组织采集。超音波引导切片检查特别适合可触摸的肿块，通常用于乳房、甲状腺、肝臟、肾臟和其他软组织的切片检查，并且可以进行即时成像。

应用范例 改进应用程式以提高乳房切片的准确性

切片检查引导系统对于脑部切片检查至关重要，可以最大限度地减少对周围健康组织的损害并提高准确性。先进的切片检查引导系统，例如立体定位切片检查框架和神经导航系统，使外科医生能够精确定位大脑内病变的位置，从而减少手术的侵入性并改善整体治疗结果。切片检查引导系统对于乳房切片中组织取样技术的准确性非常重要。 3D 影像和电脑辅助检测等切片检查引导技术的创新正在提高乳房切片的准确性，并帮助识别使用传统方法难以追踪的病变。

最终用户医院采用切片检查引导系统可以为诊断应用提供高品质的影像。

诊断中心是进行医学测试和诊断影像以诊断患者病情的设施。为了应对空间限制，这些中心倾向于青睐占地面积小且具有成本效益的切片检查引导系统。医院是初级保健机构，需要全面的切片检查引导系统，以适应大量患者和广泛的程序需求。这些系统必须提供更高的影像品质和互通性，以便与多个医院部门合作。研究和学术机构经常使用切片检查引导系统进行实验和教育程序。肿瘤科和胃肠科等专科诊所需要针对特定类型切片检查的切片检查引导系统。这些诊所需要高度准确的切片检查系统，并根据他们经常遇到的特定解剖结构和病理情况进行客製化。

区域洞察

美洲地区的特点是拥有先进的医疗基础设施、较高的医疗支出以及对早期诊断和个人化医疗的重视，这推动了对先进切片检查引导系统的需求。此外，该地区仍然是寻求提高癌症诊断性能的创新新兴企业和老牌公司的中心。由于强有力的医疗政策和既定的报销框架，切片检查引导系统已在欧盟 (EU) 广泛采用。强调以先进医疗设备为核心的高品质医疗保健。欧盟法规环境也透过资助计画支持创新并促进公私研究合作。亚太地区是切片检查引导系统市场成长最快的地区。在中国，对医疗保健的大量投资和公众对癌症的认识不断提高是推动切片检查指导系统需求的主要因素。中国政府的医疗改革努力和对新兴医疗技术的重视正在推动先进切片检查系统的采用。技术创新、高医疗保健标准和人口迅速老化正在推动日本对切片检查引导系统的需求。

FPNV定位矩阵

FPNV定位矩阵对于评估切片检查引导系统市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对切片检查引导系统市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.切片检查引导系统市场的市场规模和预测是多少？

2.在切片检查引导系统市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.切片检查引导系统市场的技术趋势和法规结构是什么？

4.切片检查引导系统市场主要供应商的市场占有率是多少？

5. 进入切片检查引导系统市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 需要诊断程序的癌症和慢性疾病的发生率增加
      • 人们对切片检查治疗的兴趣日益浓厚
      • 政府的早期诊断宣传活动和倡议
    • 抑制因素
      • 专门训练的需要和切片检查系统的不准确性
    • 机会
      • 切片检查引导系统的技术进步
      • 切片检查手术的优惠报销政策
    • 任务
      • 与切片检查引导系统相关的技术复杂性
  • 市场区隔分析
    • 产品：人们对超音波引导切片检查以提高成像能力的兴趣日益浓厚
    • 应用：改进应用以提高乳房切片准确性
    • 最终用途：医院使用的切片检查引导系统可为诊断应用提供高品质影像
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章切片检查引导系统市场：副产品

  • MRI导引切片检查
  • 立体定位切片检查
  • 超音波引导切片检查

第七章切片检查引导系统市场：依应用分类

  • 脑部切片检查
  • 乳房切片
  • 肺
  • 摄护腺

第八章切片检查引导系统市场：依最终用途

  • 诊断中心
  • 医院
  • 研究/学术机构
  • 专科诊所

第九章美洲切片检查引导系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太切片检查引导系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲/中东/非洲切片检查引导系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • FDA核准用于乳房切片的 MRI 相容机器人系统
    • Stryker 推出有颅脑导引软体的 Q Guidance
    • GE医疗集团宣布收购IMACTIS协议，以增强介入指导能力
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-C271879142B5

[191 Pages Report] The Biopsy Guidance System Market size was estimated at USD 1.44 billion in 2023 and expected to reach USD 1.54 billion in 2024, at a CAGR 7.34% to reach USD 2.38 billion by 2030.

The biopsy guidance system market encompasses the sales and development of medical devices and software that assist physicians in accurately locating the site for biopsy procedures. These biopsy guidance systems utilize a variety of modalities such as ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), and other image-guided technologies to provide real-time assistance in accurately locating and targeting abnormal tissue for a biopsy. The growing incidences of cancer and gastrointestinal diseases is increasing the need for biopsy guidance systems. The rising awareness of breast cancer treatment & diagnosis and increasing preference for minimally invasive biopsy treatments has significantly contributing to the market growth. However, high cost associated with the production of biopsy guidance systems may limit the adoption of biopsy guidance systems. Technical complexities associated with biopsy guidance systems are also a concerning factor for the market growth. Moreover, the technological advancements in biopsy guidance systems is expected to create significant growth potential in the market. Improved healthcare infrastructure and healthcare spending are also anticipated to generate attractive opportunities for the market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.44 billion
Estimated Year [2024] USD 1.54 billion
Forecast Year [2030] USD 2.38 billion
CAGR (%) 7.34%

Product: Increasing inclination towards ultrasound guided biopsy for improved imaging capabilities

The MRI-guided biopsy is a minimally invasive procedure that utilizes magnetic resonance imaging (MRI) to aid in the precise location of a lesion within the body for tissue sampling. The MRI-guided biopsy is preferred in accessing abnormalities in case lesions are not visible using ultrasound or X-ray imaging. A stereotactic-guided biopsy employs mammographic imaging to locate and sample suspicious areas, particularly within the breast tissue. Stereotactic-guided biopsies provide high accuracy and cost-effectiveness, making them a preferred choice for outpatient settings. An ultrasound-guided biopsy is a widely employed technique that uses ultrasonography to assist in needle placement for tissue sampling. The ultrasound-guided biopsy is particularly suitable for palpable masses and commonly used for biopsies of the breast, thyroid, liver, kidneys, and other soft tissues, offering real-time imaging capabilities.

Application: Improved applications for breast biopsies for enhanced accuracy

Biopsy guidance systems are vital in brain biopsies to minimize damage to surrounding healthy tissue and improve precision. Advanced biopsy guidance systems, such as stereotactic biopsy frames or neuronavigation systems, enable surgeons to pinpoint the lesion's exact location within the brain, reducing the procedure's invasiveness and improving overall outcomes. Biopsy guidance systems are important in breast biopsies due to accuracy in tissue sampling procedures. Innovations in biopsy guidance technology, such as 3D imaging and computer-aided detection, are enhancing the precision of breast biopsies and helping to identify lesions that are difficult to track with conventional methods.

End-Use: Adoption of biopsy guidance systems in hospitals to enable high-quality imaging for diagnostic applications

Diagnostic centers are facilities that perform medical testing and imaging to diagnose patient conditions. These centers tend to favor cost-effective biopsy guidance systems with a smaller footprint to accommodate space constraints. Hospitals are primary healthcare facilities that require comprehensive biopsy guidance systems that can cater to high patient volumes and broad procedural needs. These systems must provide higher imaging quality and interoperability to align with multiple hospital departments. Research and academic institutes often utilize biopsy guidance systems for experimental and educational procedures. Specialty clinics, such as oncology or gastroenterology practices, require specialized biopsy guidance systems for particular types of biopsies. These clinics have a need for biopsy systems that provide precision and are tailored to the specific anatomy and conditions they frequently encounter.

Regional Insights

The Americas region is characterized by the presence of advanced healthcare infrastructure, higher healthcare spending, and a greater emphasis on early diagnosis and personalized medicine, which fuels the need for sophisticated biopsy guidance systems. Additionally, this region remains a hub for innovative startups and established companies seeking to improve the performance of cancer diagnostics. The European Union is associated with the widespread adoption of biopsy guidance systems due to the region's strong healthcare policies and well-established reimbursement frameworks. There is an emphasis on quality healthcare with a focus on advanced medical devices. The EU's regulatory environment also supports innovation through funding initiatives and facilitates research collaborations between private and public players. Asia Pacific is a rapidly growing region in the biopsy guidance system market. In China, large-scale investments in healthcare and growing public awareness about cancer are key factors propelling the need for biopsy guidance systems. The Chinese government's initiatives to reform healthcare and emphasis on emerging medical technologies have driven the adoption of advanced biopsy systems. Technological innovation, high healthcare standards, and a rapidly aging population drive Japan's need for biopsy guidance systems.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biopsy Guidance System Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopsy Guidance System Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biopsy Guidance System Market, highlighting leading vendors and their innovative profiles. These include Argon Medical Devices, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biobot Surgical Pte Ltd., Body Vision Medical Ltd., Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Danaher Corporation, Fujifilm Holdings Corporation, GE Healthcare, Hologic, Inc., IMS Giotto S.p.A, Inomed Health Limited, INRAD Inc., IZI Medical Products, KOELIS, Koninklijke Philips N.V., KPI Healthcare India pvt Ltd, Mauna Kea Technologies, Medtronic PLC, Merit Medical Systems, NeoDynamics AB, Olympus Corporation, Planmed Oy, Siemens Healthineers AG, STERYLAB S.r.l., Stryker Corporation, and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Biopsy Guidance System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • MRI Guided Biopsy
    • Stereotactic Guided Biopsy
    • Ultrasound Guided Biopsy
  • Application
    • Brain Biopsy
    • Breast Biopsy
    • Lungs
    • Prostate
  • End-Use
    • Diagnostic Centers
    • Hospitals
    • Research & Academic Institutes
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biopsy Guidance System Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopsy Guidance System Market?

3. What are the technology trends and regulatory frameworks in the Biopsy Guidance System Market?

4. What is the market share of the leading vendors in the Biopsy Guidance System Market?

5. Which modes and strategic moves are suitable for entering the Biopsy Guidance System Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of cancer and chronic diseases requiring diagnostic procedures
      • 5.1.1.2. Increasing preference for minimally invasive biopsy treatments
      • 5.1.1.3. Government campaigns and initiatives for early disease diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. Need for specialized training and inaccuracy of biopsy systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in biopsy guidance systems
      • 5.1.3.2. Favorable reimbursement policies for biopsy procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Technical complexities associated with biopsy guidance system
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing inclination towards ultrasound guided biopsy for improved imaging capabilities
    • 5.2.2. Application: Improved applications for breast biopsies for enhanced accuracy
    • 5.2.3. End-Use: Adoption of biopsy guidance systems in hospitals to enable high-quality imaging for diagnostic applications
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Biopsy Guidance System Market, by Product

  • 6.1. Introduction
  • 6.2. MRI Guided Biopsy
  • 6.3. Stereotactic Guided Biopsy
  • 6.4. Ultrasound Guided Biopsy

7. Biopsy Guidance System Market, by Application

  • 7.1. Introduction
  • 7.2. Brain Biopsy
  • 7.3. Breast Biopsy
  • 7.4. Lungs
  • 7.5. Prostate

8. Biopsy Guidance System Market, by End-Use

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Hospitals
  • 8.4. Research & Academic Institutes
  • 8.5. Specialty Clinics

9. Americas Biopsy Guidance System Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biopsy Guidance System Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biopsy Guidance System Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. FDA Clears MRI-Compatible Robotics System for Breast Biopsy
    • 12.3.2. Stryker Launches Q Guidance with Cranial Guidance Software
    • 12.3.3. GE HealthCare Announces Agreement to Acquire IMACTIS to Strengthen Capabilities in Interventional Guidance
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BIOPSY GUIDANCE SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BIOPSY GUIDANCE SYSTEM MARKET DYNAMICS
  • FIGURE 7. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. BIOPSY GUIDANCE SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. BIOPSY GUIDANCE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPSY GUIDANCE SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY MRI GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY MRI GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STEREOTACTIC GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STEREOTACTIC GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND GUIDED BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND GUIDED BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BRAIN BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BRAIN BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY LUNGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY LUNGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PROSTATE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PROSTATE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 49. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 50. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 55. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 56. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 61. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 62. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 84. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 89. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 95. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 96. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 101. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 102. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 107. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 108. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 113. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 120. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 125. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 126. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 137. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 143. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 149. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 150. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 163. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 169. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 170. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 175. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 176. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 181. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 182. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 187. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 193. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 199. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 200. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 211. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 217. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 223. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 224. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 229. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 235. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 242. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 253. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 259. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 260. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 266. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 271. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 272. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 289. BIOPSY GUIDANCE SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 290. BIOPSY GUIDANCE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023